Inventor
Ming Lei
Inventor
Acton, MA, US
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07KPeptides18%
C12NMicroorganisms or enzymes15%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture4%
C12YEnzymes4%
C07DHeterocyclic compounds2%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms2%
PatentTitleYear
11,118,171Recombinant corynebacterium glutamicum for producing lysine by biofilm continuous fermentation and construction method thereof202111,098,331Method for producing lysine by utilizing adsorption and immobilized fermentation of recombinant corynebacterium glutamicum202110,653,791Antibodies comprising modified heavy constant regions2020RE047860Methods of treating cancer with low density lipoprotein-related protein 6 (LRP6)--half life extender constructs202010,525,083Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain202010,253,086CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell201910,167,343Antibodies against CD73201910,100,129Antibodies against CD73 and uses thereof20189,771,562'Method for culture of human and mouse prostate organoids and uses thereof'20179,605,080'Antibodies against CD73'20179,290,573'Therapeutic low density lipoprotein-related protein 6 (LRP6) multivalent antibodies'20169,173,960'Methods of treating cancer with low density lipoprotein-related protein 6 (LRP6)—half life extender constructs'20159,084,792'Method for preparing acyclovir 2/3 hydrate'20158,970,318'Transforming circuit'20158,883,735'Low density lipoprotein-related protein 6 (LRP6)-half life extender constructs'2014Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2014–2020Patents assigned to NOVARTIS AG (6)· patent assignee history
2014–2020Based in Acton, MA, US· patent location history
2015–2016Patents assigned to LEI MING (2)· patent assignee history
2017–2020Patents assigned to BRISTOL MYERS SQUIBB CO (4)· patent assignee history
2017–2020Based in Princeton, NJ, US· patent location history
2017Based in New York, NY, US· patent location history
2019–2020Patents assigned to UNIV PENNSYLVANIA (2)· patent assignee history
2019Based in Cambridge, MA, US· patent location history
2021Patents assigned to NANJING UNIVERSITY OF TECHNOLOGY (2)· patent assignee history
2021Based in Jiangsu, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 6 | 2014–2020 |
| BRISTOL MYERS SQUIBB CO | 4 | 2017–2020 |
| LEI MINGself | 2 | 2015–2016 |
| NANJING UNIVERSITY OF TECHNOLOGY | 2 | 2021 |
| UNIV PENNSYLVANIA | 2 | 2019–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Acton, Massachusetts, US | 5 | 2014–2020 |
| Princeton, New Jersey, US | 4 | 2017–2020 |
| Jiangsu, CN | 2 | 2021 |
| Cambridge, Massachusetts, US | 1 | 2019 |
| New York, New York, US | 1 | 2017 |